AI assistant
MACROGENICS INC — Director's Dealing 2018
Jan 26, 2018
34129_dirs_2018-01-26_7f73a512-176a-4243-8d47-c2ad83f1054f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2018-01-24
Reporting Person: Risser Eric Blasius (Sr VP & Chief Business Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-01-24 | Common Stock | M | 3000 | $0.94 | Acquired | 12100 | Direct |
| 2018-01-24 | Common Stock | S | 3000 | $22.50 | Disposed | 9100 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-01-24 | Employee stock option (right to buy) | $0.94 | M | 3000 | Disposed | 2019-03-23 | Common Stock (3000.0) | Direct |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted 11/14/17.
F2: The Form 4, as originally filed on 1/25/18, incorrectly reported the sale price. The Form 4, as amended by this Form 4/A, correctly reports such information.
F3: The price reported in Column 4 is a weighted average price. This transaction was executed in multiple trades at prices ranging from $22.50 to $22.51. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.